DBI, CMO for sterile forms.
DBI’s aim is to provide each actor in the biotechnological research and the pharmaceutical industry a production plant of small batches (till 8.000 vials and 20.000 syringes) of injectable, liquid or freeze-dried products for highly potent drugs with:
- A highly qualified team
- Specific design and strong organization for small batches
- Specific design and strong organization for process transfer and scale-up
- Compounding under isolator class C
- Filling, stoppering and capping under class A isolator
- Total containment, no human intervention in sterile area
- Highly potent API, biological and biotechnological API,
- State of the art plant
- State of the art equipment
- Explosion proof, specific design for the filling line and the lyophilizer
- Environmental safety: specific cleaning
Manufacturing operations: